Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [11770]

AACR 2021: Copanlisib-rituximab combination cuts lymphoma progression or death by nearly half in CHRONOS-3 trial

AACR 2021: Copanlisib-rituximab combination cuts lymphoma progression or death by nearly half in CHRONOS-3 trial

AACR 2021: Cancer aneuploidy may predict responses to immunotherapy in patients with non-small cell lung cancer

AACR 2021: Cancer aneuploidy may predict responses to immunotherapy in patients with non-small cell lung cancer

Genes and immune cells predict immunotherapy success in bladder cancer

Genes and immune cells predict immunotherapy success in bladder cancer

Artificial Intelligence could 'crack the language of cancer and Alzheimer's'

Artificial Intelligence could 'crack the language of cancer and Alzheimer's'

Excellent outcomes reported for first targeted therapy for paediatric Hodgkin lymphoma

Excellent outcomes reported for first targeted therapy for paediatric Hodgkin lymphoma

Scientists identify potential new target for lung cancer treatment

Scientists identify potential new target for lung cancer treatment

Mutations in overlooked DNA could have profound impact on survival for bowel cancer patients

Mutations in overlooked DNA could have profound impact on survival for bowel cancer patients

'Patchwork' tumours prevalent across multiple cancer types

'Patchwork' tumours prevalent across multiple cancer types

Novel "hydrogel" carriers for anti-cancer drugs offer new hope for cancer treatment

Novel "hydrogel" carriers for anti-cancer drugs offer new hope for cancer treatment

Parkinson's, cancer & type 2 diabetes all share a key element that drives disease

Parkinson's, cancer & type 2 diabetes all share a key element that drives disease

More from ecancer